| Product Code: ETC11642962 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Cinv Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Cinv Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Cinv Market - Industry Life Cycle |
3.4 Japan Cinv Market - Porter's Five Forces |
3.5 Japan Cinv Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Japan Cinv Market Revenues & Volume Share, By Formulation, 2021 & 2031F |
3.7 Japan Cinv Market Revenues & Volume Share, By Emetogenic Risk Level, 2021 & 2031F |
3.8 Japan Cinv Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Japan Cinv Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chemotherapy-induced nausea and vomiting (CINV) cases in Japan |
4.2.2 Growing awareness about the importance of managing CINV effectively |
4.2.3 Technological advancements in antiemetic drugs and treatment options |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Japan |
4.3.2 High cost associated with advanced CINV treatment options |
4.3.3 Limited access to specialized healthcare facilities in certain regions of Japan |
5 Japan Cinv Market Trends |
6 Japan Cinv Market, By Types |
6.1 Japan Cinv Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Japan Cinv Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 Japan Cinv Market Revenues & Volume, By 5HT3 Receptor Antagonist, 2021 - 2031F |
6.1.4 Japan Cinv Market Revenues & Volume, By Neurokinin1 (NK1) Receptor Antagonists, 2021 - 2031F |
6.1.5 Japan Cinv Market Revenues & Volume, By Corticosteroids, 2021 - 2031F |
6.1.6 Japan Cinv Market Revenues & Volume, By Cannabinoids, 2021 - 2031F |
6.1.7 Japan Cinv Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Japan Cinv Market, By Formulation |
6.2.1 Overview and Analysis |
6.2.2 Japan Cinv Market Revenues & Volume, By Injectables, 2021 - 2031F |
6.2.3 Japan Cinv Market Revenues & Volume, By Oral Tablets, 2021 - 2031F |
6.2.4 Japan Cinv Market Revenues & Volume, By Transdermal Patches, 2021 - 2031F |
6.3 Japan Cinv Market, By Emetogenic Risk Level |
6.3.1 Overview and Analysis |
6.3.2 Japan Cinv Market Revenues & Volume, By Highly Emetogenic Chemotherapy (HEC), 2021 - 2031F |
6.3.3 Japan Cinv Market Revenues & Volume, By Moderately Emetogenic Chemotherapy (MEC), 2021 - 2031F |
6.3.4 Japan Cinv Market Revenues & Volume, By Low Emetogenic Chemotherapy (LEC), 2021 - 2031F |
6.4 Japan Cinv Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Japan Cinv Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Japan Cinv Market Revenues & Volume, By Cancer Research Institutes, 2021 - 2031F |
6.4.4 Japan Cinv Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.4.5 Japan Cinv Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.6 Japan Cinv Market Revenues & Volume, By Drug Stores, 2021 - 2031F |
7 Japan Cinv Market Import-Export Trade Statistics |
7.1 Japan Cinv Market Export to Major Countries |
7.2 Japan Cinv Market Imports from Major Countries |
8 Japan Cinv Market Key Performance Indicators |
8.1 Patient satisfaction with CINV management services |
8.2 Adoption rate of new antiemetic drugs in Japan |
8.3 Number of clinical trials and research studies conducted on CINV treatments |
8.4 Rate of adherence to CINV treatment guidelines |
8.5 Patient-reported outcomes related to CINV symptom control |
9 Japan Cinv Market - Opportunity Assessment |
9.1 Japan Cinv Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Japan Cinv Market Opportunity Assessment, By Formulation, 2021 & 2031F |
9.3 Japan Cinv Market Opportunity Assessment, By Emetogenic Risk Level, 2021 & 2031F |
9.4 Japan Cinv Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Japan Cinv Market - Competitive Landscape |
10.1 Japan Cinv Market Revenue Share, By Companies, 2024 |
10.2 Japan Cinv Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here